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Abstract The essential trace mineral selenium is an
important determinant of oxidative stress susceptibility,
with several studies showing an inverse relationship
between selenium intake and cancer. Because different
chemical forms of selenium have been reported to have
varying bioactivity, there is a need for nutrigenomic studies
that can comprehensively assess whether there are diver-
gent effects at the molecular level. We examined the gene
expression proﬁles associated with selenomethionine (SM),
sodium selenite (SS), and yeast-derived selenium (YS) in
the intestine, gastrocnemius, cerebral cortex, and liver of
mice. Weanling mice were fed either a selenium-deﬁcient
(SD) diet (\0.01 mg/kg diet) or a diet supplemented with
one of three selenium sources (1 mg/kg diet, as either SM,
SS or YS) for 100 days. All forms of selenium were
equally effective in activating standard measures of sele-
nium status, including tissue selenium levels, expression of
genes encoding selenoproteins (Gpx1 and Txnrd2), and
increasing GPX1 enzyme activity. However, gene expres-
sion proﬁling revealed that SS and YS were similar (and
distinct from SM) in both the expression pattern of indi-
vidual genes and gene functional categories. Furthermore,
only YS signiﬁcantly reduced the expression of Gadd45b in
all four tissues and also reduced GADD45B protein levels
in liver. Taken together, these results show that gene
expression proﬁling is a powerful technique capable of
elucidating differences in the bioactivity of different forms
of selenium.
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Introduction
The trace mineral selenium plays a key role in several
biological processes, including the response to oxidative
stress (Brenneisen et al. 2005), DNA damage and repair
(Seo et al. 2002a, b), cancer susceptibility (Rayman 2005),
and viral pathogenicity (Beck 2007). Selenium is fed to
animals and humans either as inorganic salts, such as
sodium selenite (SS) and selenate, as selenomethionine
(SM) or as yeast-derived selenium (YS) that contains
selenium as protein-bound SM and other less characterized
selenium organic compounds (McSheehy et al. 2005;I p
et al. 2000). While some studies suggest that inorganic
selenium (selenite or selenate) is less bioavailable or less
bioactive than SM or YS (Rider et al. 2010; Mahmoud and
Edens 2003; Qin et al. 2007), other studies suggest that the
source of selenium does not differentially affect parameters
such as growth or expression and activity of selenoproteins
(Qin et al. 2007, 2009; Wang et al. 2010). A human study
that addressed the effects of different forms of selenium on
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reﬂects the SM content of yeast and that selenium in the
form of SM is better absorbed than SS based on urinary
selenium excretion (Burk et al. 2006).
The selection of an appropriate source of selenium for
supplementation studies is relevant to human health
because extensive epidemiological data suggest a link
between selenium status and cancer at various sites, and a
number of trials testing the effects of selenium supple-
mentation in cancer chemoprevention have led to positive
results (Reid et al. 2006; Dufﬁeld-Lillico et al. 2003). One
study in humans that involved selenium supplementation in
the form of YS was associated with a marked reduction in
cancer incidence and mortality (Clark et al. 1996). These
and other observations led to the design of the SELECT
study, a phase III randomized, placebo-controlled trial
testing the role of SM and/or vitamin E supplementation on
prostate cancer incidence. The trial was terminated early
due to observations suggesting negative effects of selenium
and/or vitamin E intake. However, a major concern in the
design of this study was the selection of SM as the
chemical form of selenium to be used; SM was selected as
it is the most abundant selenium chemical form in YS, and
also because the chemical composition of independent
batches of YS was thought to be variable (Lippman et al.
2005, 2009). Nevertheless, the use of SM in a study
designed to conﬁrm a previous study performed with a
different chemical form of selenium seems problematic and
could yield contradictory results. In the absence of detailed
knowledge of the biological properties of different sele-
nium chemical forms, rational choice of chemical source of
selenium for chemoprevention studies is not possible.
Because mechanistic studies of different forms of sele-
nium at the molecular level are lacking, we investigated the
effects of SS, SM, and YS on several parameters in the
mouse, including global gene expression proﬁles in mul-
tiple tissues, the effects on key selenoproteins, and oxida-
tive DNA damage. Our ﬁndings suggest striking
differences regarding the biological activities of different
chemical forms of selenium.
Materials and methods
Animals and diets
Male and female C57BL6/J mice were purchased from
Jackson Labs (Bar Harbor, Maine), maintained as breeding
pairs, and received LabDiet 5001 ad libitum. Immediately
after weaning at 21 days, male mice were randomly
assigned to a selenium-deﬁcient diet (SD) or a diet con-
taining 1 mg selenium/kg diet from one of three sources:
L-selenomethionine (SM, Sigma-Aldrich, St. Louis,
Missouri), sodium selenite (SS, Sigma-Aldrich, St. Louis,
Missouri), or yeast selenium (YS, Sel-Plex
, Alltech Inc.,
Nicholasville, Kentucky).
Experimental diets were torula yeast-based diets, pre-
pared by Harlan-Teklad (Madison, WI) and described in
detailelsewhere(Raoetal.2001).WesupplementedtheSD,
SS, and SM diets with an equal amount of non-selenium-
enriched yeast (selenium\0.5 ppm on a product basis) to
control for the effects of non-selenium-related yeast com-
ponents.Seleniumlevelsindietarypremixeswereevaluated
by atomic absorption spectroscopy (Connolly et al. 2003);
selenium level in the SD diet was conﬁrmed to be
\0.03 ppm, whereas levels in the supplemented diets were
YS = 1.05 ppm, SS = 0.99 ppm, and SM = 1.02 ppm.
Mice were housed two to three per cage, and food and water
were provided ad libitum. At 100 days of age, mice were
euthanized by cervical dislocation, and tissues were rapidly
dissected, ﬂash-frozen in liquid nitrogen, and stored at
-80C for later analysis. All procedures were approved by
the Animal Care Committee at the William S. Middleton
Veterans Administration Hospital.
Selenium analysis in tissues
Wefocusedourstudiesonfourtissues:cerebralcortex,small
intestine (3-cm section corresponding to the jejunum), gas-
trocnemius muscle, and liver. Tissues from seven mice per
diet were used for measurement of selenium content using
molecular ﬂuorescence spectrometry following wet diges-
tion and reaction with 2,3-diaminonapthalene [described
previously (Koh and Benson 1983)]. Bovine liver Standard
Reference Material from the National Institute of Standards
andTechnologywasusedasastandard.Dietaryeffectswere
analyzed by one-way analysis of variance; if the overall
treatment effect was statistically signiﬁcant (P\0.05),
differences between individual diets were determined using
Tukey’s post hoc tests.
Gene expression proﬁling and pathway analysis
For each of the four tissues described above, we performed
gene expression proﬁling on ﬁve mice from each diet.
Affymetrix Mouse Genome 430A arrays were used to
measure gene expression in the intestine, and Mouse
Genome 430 2.0 arrays were used for gastrocnemius
muscle, cerebral cortex, and liver. At the time of the
analysis, the Mouse Genome 430A array represented
12,445 unique genes, and the Mouse Genome 430 2.0 array
represented 20,318 unique genes. Details regarding sample
preparation and array hybridization are described else-
where (Lee et al. 1999). Brieﬂy, total RNA was isolated
from individual tissues using TRIzol (Life Technologies)
and was processed to biotin-labeled cRNA according to
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123Affymetrix protocols. Microarrays were scanned with the
Affymetrix GeneArray Scanner (Affymetrix), and the
value for each RNA abundance was automatically calcu-
lated with the Affymetrix GeneChip Analysis Suite version
3.3 after scanning. When a gene was represented by mul-
tiple probe sets on an array, only the probe set having the
greatest signal intensity (averaged across all 20 arrays
within a tissue) was included for analysis. A gene was
considered to be signiﬁcantly changed in expression when
the P value for a two-tailed t-test was\0.01.
We performed a pathway analysis using parametric
analysis of gene set enrichment (PAGE) to identify gene
functional classes that were affected by selenium supple-
mentation (Kim and Volsky 2005). Gene expression data
were annotated with functional data from the Gene
Ontology (GO) consortium (http://www.geneontology.org).
We only analyzed GO terms that were annotated at Level 3
or greater and were represented by at least 10 but not more
than 1,000 genes. A GO term was considered to be sig-
niﬁcantly changed by treatment if the P value was\0.01.
Real-time RT-PCR conﬁrmation of DNA
microarray results
To conﬁrm the DNA microarray ﬁndings, we used gastroc-
nemius muscle and liver from the microarray study to mea-
sure the expression of two genes changed by all diets using
reverse transcriptase quantitative PCR (RT-qPCR; gluta-
thione peroxidase 1, Gpx1, and thioredoxin reductase 2,
Txnrd2). The RT-qPCR assay was performed using primers
from Applied Biosystems on an Eppendorf realplex
2
instrument using the d-dCt method as described previously
(Barger et al. 2008a). Beta-2-microglobulin (B2m) and
mitochondrial ribosomal protein L13 (Mrpl13) were used as
normalizinggenesinliverandmuscle,respectively,because
the microarray data revealed that they were abundantly
expressed and unchanged by any selenium treatment. Die-
tary effects were analyzed by one-way analysis of variance;
if the overall treatment effect was statistically signiﬁcant
(P\0.05), differences between individual diets were
determined using Tukey’s post hoc tests.
Western blot analysis and selenoprotein activity
Microarray analysis also revealed that the growth arrest
and DNA-damage-inducible 45 beta gene (Gadd45b) was
decreased in expression by one or more selenium sources
in every tissue studied. To conﬁrm this ﬁnding at the
protein level, we quantiﬁed the abundance of the protein
encoded by this gene by western blotting in liver. Tissues
were homogenized on ice in seven volumes of cold protein
extraction buffer that consisted of 20 mM HEPES pH 7.9,
125 mM NaCl, 0.1% Igepal (NP-40), 0.1% Triton X-100,
and 1 mM EDTA. Homogenates were clariﬁed by centri-
fugation at 4C for 10 min at 18,000g. Supernatants were
aliquoted and stored at -80C. Samples for western blot-
ting were electrophoresed in NuPAGE 7% polyacrylamide
Tris–acetate gels (Invitrogen) and transferred to nitrocel-
lulose membranes using the iBlot Dry Blotting System
(Invitrogen). Membranes were blocked in 0.5% gelatin in
TBST (137 mM NaCl, 0.1% Tween-20, 20 mM Tris, pH
7.6) for 1 h. Primary and secondary antibodies were diluted
in 0.5% gelatin in TBST. Rabbit polyclonal anti-
GADD45b (H-70) was purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). HRP-linked goat anti-rabbit
IgG was purchased from Pierce (Rockford, IL) as part of
the Dura SuperSignal West chemiluminescent substrate kit,
which was used to detect antibodies. Chemiluminescent
bands were visualized and analyzed using a UVP Bio-
imaging Systems (Upland, CA). MemCode
TM Reversible
Protein Stain Kit was purchased from Pierce and used to
control for protein loading. A loading correction factor
based on the memcode protein band intensity data was used
to adjust the GADD45b band intensity data.
Glutathione peroxidase and thioredoxin reductase
enzyme activities in liver were measured using commer-
cially available kits (Cayman Chemical); protein homog-
enates were prepared from the same source material used in
the microarray analysis, and enzyme activity was measured
according to the manufacturer’s instructions. Dietary
effects were analyzed by one-way analysis of variance; if
the overall treatment effect was statistically signiﬁcant
(P\0.05), differences between individual diets were
determined using Tukey’s post hoc tests.
Oxidative damage to DNA
DNA damage was quantiﬁed from DNA isolated from liver
tissueofmiceusingahighlysensitiveHPLC/EC/UVsystem
as described previously (Barger et al. 2008b). Samples were
compared against a calibration curve with known standards
toquantifythelevelsoftheoxidativeproducts8-hydroxy-20-
deoxyguanosine/10
6 20-deoxyguanosine (8-oxo-dG). Data
wereanalyzedbyone-wayanalysisofvariance;iftheoverall
treatment effect was statistically signiﬁcant (P\0.05),
differences between individual diets were determined using
Tukey’s post hoc tests.
Results
Effects of experimental diets on tissue selenium
Mice consuming the SD diets had low selenium levels in
all tissues examined, below 0.1 lg selenium/g tissue
(Fig. 1). When compared to the SD diet, SM and YS
Genes Nutr (2012) 7:155–165 157
123signiﬁcantly elevated selenium levels in all four tissues; SS
elevated tissue selenium levels compared to SD in all tis-
sues except for gastrocnemius. When comparing the dif-
ferent sources of selenium to one another, the effect of diet
was different depending on the tissue studied: In cerebral
cortex and intestine, levels of selenium were highest in
SM, intermediate in YS, and lowest in the SS diet
(SM[YS[SS); in gastrocnemius, selenium levels were
similar between SM and YS diets, but higher than the SS
diet (SM = YS[SS). In liver, selenium levels were
highest in the SM, intermediate in the YS, and lowest in the
SS diet (SM C YS C SS).
Overview of gene expression patterns
Selenium supplementation with SM, SS, or YS resulted in
the differential expression of many (hundreds to thousands)
of genes, with some tissues being more responsive than
others (Fig. 2). Gastrocnemius and cerebral cortex were the
most responsive to selenium supplementation, with 21 and
17%, respectively, of the genes represented on the array
being changed in expression by at least one diet. In liver,
12% of the genes represented on the array were changed in
expression by at least one diet, and in the intestine, only 4%
of the genes represented on the array were changed in
expression by at least one diet. Despite the fact that tissue
selenium levels were highest in response to the SM diet,
SM supplementation affected the expression of the least
number of genes (compared to SS and YS). In contrast,
tissue selenium levels were lowest in response to the SS
diet, but SS affected the expression of more genes than
either SM or YS.
For each tissue, there were groups of genes changed in
expression by only one selenium source, groups of genes
changed by two selenium sources, and a group of genes
changed in expression by all three treatments (Fig. 2). In
general, if a gene was signiﬁcantly changed in expression
by more than one selenium source, the direction of the
change in expression (increased or decreased) was similar
for the other treatment(s); this similarity is represented by
the fractions within the intersecting regions of Fig. 2.A
remarkable ﬁnding was that the overlap between SS and
YS was higher than that of any other pair of treatments. For
example, in the small intestine, 86 genes were signiﬁcantly
changed in expression by both the SS and YS diets,
Fig. 1 Tissue levels of selenium (mean ? SEM) in four tissues from
mice fed a selenium-deﬁcient (SD) or selenium-supplemented diet
(SM selenomethionine, SS sodium selenite, and YS yeast selenium).
Within a tissue, different letters indicate a statistically signiﬁcant
difference between treatments (P\0.05)
Fig. 2 Effect of selenium supplementation on the number of
differentially expressed (P\0.01) genes in four tissues of mice.
When genes were changed by more than one treatment (shown in
intersecting regions), the denominator indicates the total number of
genes changed and the numerator indicates how many of those genes
were changed in the same direction by all treatments. If a ratio is not
shown for a given intersection, all genes were changed in the same
direction by all treatments. As described in the ‘‘Materials and
methods,’’ there were fewer genes represented on the array used for
the intestine which explains, in part, the lower number of differen-
tially expressed genes in this tissue; the percentage of differentially
expressed genes (relative to the total number of genes represented on
the array) for each tissue is stated in the ‘‘Results’’
158 Genes Nutr (2012) 7:155–165
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SM and SS diets and SM and SY diets (an abbreviated list
of genes changed in expression by more than one diet in
small intestine is shown in Table 1). This large similarity
between SS and YS diets was also observed in the other
three tissues as shown in the overlap in the Venn diagrams
in Fig. 2 (indicated by the greatest number of genes in the
overlap between SS and YS circles). A complete list of the
individual genes changed in expression by more than one
diet for all four tissues is shown in Online Resources 1–4.
Thus, the gene expression proﬁle of YS is much more
similar to that of SS, despite the fact that SM is a major
component of YS. Perhaps surprisingly, there was no gene
that was signiﬁcantly changed in expression at P\0.01 in
all tissues by all selenium diets. However, selenoprotein W
was increased in expression in all tissues and diets as
compared to SD at a lower level of statistical signiﬁcance
(P\0.05, data not shown). As discussed below, Gadd45b
was the only gene not related to selenium biology that was
changed in expression by multiple diets in every tissue.
Using RT-PCR, we examined the expression of seven
genes that showed diet-speciﬁc changes in expression in the
microarrayanalysis(Table 2).Threeofthesegenes(Cyp7b1,
Sucnr1, and Tsc22d1) showed an identical pattern of gene
expressionforboththemicroarrayandRT-PCRanalyses.For
the remaining genes, the direction of the fold change in
expression was similar between the two techniques, but the
number of signiﬁcantly different genes varied.
Pathway analysis
Similar to what was observed in the analysis of individual
genes (above), pathway analysis revealed that different
selenium sources had both individual and overlapping
effects on functional classes of genes in each tissue (Online
Resource 5–8). Figure 3 represents GO terms changed by
at least 2/3 diets and shows that all three diets tended to
have similar effects on both gastrocnemius and liver
(Fig. 3a, c, respectively), with SM having a less pro-
nounced effect in gastrocnemius. In the intestine and
cerebral cortex, however, the overall effect of the SM diet
tended to be the opposite of both the SS and YS diets
(Fig. 3b, d, respectively).
Because GO term ‘‘mitochondrial inner membrane’’
(GO:0005743) was signiﬁcantly regulated by at least two
treatments in each tissue (Fig. 3a–d), this pathway provides
a useful parameter for comparison among the different
selenium sources. In gastrocnemius, the class of genes
representing the mitochondrial inner membrane was
upregulated by all diets; in the liver, this gene class was
upregulated by SM and YS; in the intestine, this gene class
was upregulated by SM but downregulated by both SS and
YS. In cerebral cortex, SM and YS downregulated this
class of genes, but SS upregulated this gene class overall.
Thus, different sources of dietary selenium clearly have
different effects at the gene expression level.
Analysis of selenoproteins
The functional category that was most consistently and
robustly modulated by all selenium diets was the GO term
‘‘selenium binding’’ (GO:0008430), which is deﬁned as a
class of genes that ‘‘interact selectively and non-covalently
with selenium.’’ This GO term was signiﬁcantly upregu-
lated by all three diets in every tissue except for cortex
(Fig. 4a). The expression of two key genes in this GO term
was conﬁrmed by RT-qPCR in liver: Gpx1 and Txnrd2
expression was increased approximately ﬁve- and twofold
in expression, respectively, by all three diets relative to the
SD group (Fig. 4b). Total glutathione peroxidase enzy-
matic activity in liver was also signiﬁcantly increased
nearly eightfold by all three selenium diets, whereas thio-
redoxin reductase activity in liver was signiﬁcantly
increased threefold by the SM diet, with an intermediate
level of activity in the SS and YS diets (Fig. 4c).
Gadd45b and DNA oxidation
In a search for genes unrelated to selenium biology that
were consistently regulated by selenium supplementation
across tissues, we observed that the gene Gadd45b was
decreased in expression by all selenium diets in cerebral
cortex, decreased by SS and YS in gastrocnemius, and
decreased by YS only in intestine and liver (Fig. 5a).
Gadd45b is thought to be an important mediator of the
DNA damage response, and its expression is induced with
DNA damage or aging (Liu et al. 2009; Hoffman and
Liebermann 2009). Because this gene was decreased in
expression by selenomethionine in a previous study (Rao
et al. 2001), we expanded upon the microarray ﬁndings by
measuring the abundance of the protein encoded by this
gene. GADD45B protein was not different in SM and SS
diets compared to the SD diet, but was signiﬁcantly
reduced by 44% in liver of the YS diet (Fig. 5b). Finally,
we measured levels of DNA oxidation (8-oxo-dG) in the
liver of mice fed the four diets. The amount of oxidized
DNA was not signiﬁcantly affected by selenium supple-
mentation, though there was a trend toward a decreased
level of oxidized DNA (27%) in the YS diet (Fig. 5c).
Discussion
We used a nutrigenomic approach to assess the effects of
three different forms of selenium in four tissues from mice.
Because all forms of selenium corrected the alterations in
Genes Nutr (2012) 7:155–165 159
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and also corrected the reduced glutathione peroxidase
activity in the SD diet, we conclude that the different forms
of selenium (fed a 1 ppm of the diet) are equivalent in their
ability to correct a selenium deﬁciency. Nonetheless, there
appear to be distinct effects of the different forms of
selenium: We observed that yeast-derived selenium (YS)
results in overall gene expression proﬁles that are similar to
those of SS, despite the fact that YS is thought to contain
selenomethionine as the major selenium source (McSheehy
Table 1 Selected microarray
data from intestine for genes
changed in expression by at
least two diets (P\0.01)
See Online Resource 3 for
complete list






Fasl Fas ligand (TNF superfamily, member 6) 3.63 5.35 nsd
Dolpp1 Dolichyl pyrophosphate phosphatase 1 1.37 1.46 nsd
Srsf2ip Serine/arginine-rich splicing factor 2, interacting protein -1.73 -1.82 nsd
Pla1a Phospholipase A1 member A 1.84 nsd 2.26
Txnrd1 Thioredoxin reductase 1 1.7 nsd 1.86
Odc1 Ornithine decarboxylase, structural 1 1.44 nsd 1.64
Aadat Aminoadipate aminotransferase -2.84 nsd -2.91
Lrp5 Low-density lipoprotein receptor-related protein 5 nsd 4.25 3.92
Dmpk Dystrophia myotonica-protein kinase nsd 2.99 3.32
Anpep Alanyl (membrane) aminopeptidase nsd 2.45 2.62
Polr2a Polymerase (RNA) II (DNA directed) polypeptide A nsd 2.09 2.52
Rasa2 RAS p21 protein activator 2 nsd 2.65 2.33
Scly Selenocysteine lyase nsd 1.89 2.33
Leng8 Leukocyte receptor cluster (LRC) member 8 nsd 2.22 2.29
Oxct1 3-Oxoacid CoA transferase 1 nsd 2.24 2.23
Dak Dihydroxyacetone kinase 2 homolog (yeast) nsd 1.83 2.23
2210023G05Rik RIKEN cDNA 2210023G05 gene nsd 2.52 2.2
Syvn1 Synovial apoptosis inhibitor 1, synoviolin nsd 1.93 2.18
Ncstn Nicastrin nsd 1.9 2.18
Brwd1 Bromodomain and WD repeat domain containing 1 nsd 2.38 2.1
Fmo5 Flavin containing monooxygenase 5 nsd 2.27 2.06
Cic Capicua homolog (Drosophila) nsd 2.06 2.05
Tra2a Transformer 2 alpha homolog (Drosophila) nsd 2.21 2.04
Mical2 Microtubule associated monoxygenase, calponin and LIM
domain containing
nsd 1.98 2.03
Src Rous sarcoma oncogene nsd 2.01 2
Gbf1 Golgi-speciﬁc brefeldin A-resistance factor 1 nsd 1.98 2
Slc30a9 Solute carrier family 30 (zinc transporter), member 9 nsd -1.66 -1.75
Tprkb Tp53rk-binding protein nsd -1.5 -1.79
Ppp1cb Protein phosphatase 1, catalytic subunit, beta isoform nsd -1.9 -1.82
Fzd4 Frizzled homolog 4 (Drosophila) nsd -1.99 -1.89
Nans N-acetylneuraminic acid synthase (sialic acid synthase) nsd -1.99 -1.97
Cpd Carboxypeptidase D nsd -2.02 -2.04
Homer2 Homer homolog 2 (Drosophila) nsd -1.95 -2.25
Ndufab1 NADH dehydrogenase (ubiquinone) 1, alpha/beta
subcomplex, 1
nsd -2.45 -3.07
Sepw1 Selenoprotein W, muscle 1 4.86 8.15 7.15
2700094K13Rik RIKEN cDNA 2700094K13 gene 5.25 3.82 4.73
Gpx1 Glutathione peroxidase 1 4.34 4.06 4.69
Gpx3 Glutathione peroxidase 3 3.63 2.74 2.95
Dio1 Deiodinase, iodothyronine, type I 1.95 2.87 2.28
Pias1 Protein inhibitor of activated STAT 1 1.27 1.61 1.63
Pnpo Pyridoxine 50-phosphate oxidase 1.25 1.2 1.31
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123et al. 2005; Ip et al. 2000). In addition, pathway analysis
suggests that SM, SS, and YS differentially impact key
cellular functions, including mitochondrial function and
metabolism. Finally, we found that only YS is associated
with a pattern of decreased DNA damage.
We note that all selenium sources resulted in a large
number of signiﬁcant changes in gene expression, ranging
from 4 to 21% of all genes represented in the array for
intestine and gastrocnemius, respectively. This ﬁnding is in
agreement with our previous study of the effects of sele-
nium in mouse intestine, which showed changes in the
expression of a large number of genes in response to dif-
ferent selenium sources (Rao et al. 2001). Given the central
role of selenium in the cellular antioxidant system, it
appears likely that most changes in gene expression in
response to alterations in selenium status are secondary to
alterations in redox status. Indeed, many transcriptional
factors are redox-regulated, including NF-kB (Kabe et al.
2005), NRF2 (Giudice et al. 2010), and the FOXO family
of transcriptional factors (Keizer et al. 2011). As an
example of such effects, we note that the selenium-
dependent thioredoxin reductase modulates thioredoxin
activity, which directly regulates the activity of NF-kB and
AP-1 (Hirota et al. 1997). Thus, changes in the activity of
multiple redox-sensitive transcription factors may lead to
alterations in the expression of a large number of genes in
response to changes in selenium status.
The observation that gene expression patterns and gene
functional categories are highly similar between SS and YS
diets was surprising, given that selenomethionine is
thought to be the principal selenium form in yeast-derived
selenium (McSheehy et al. 2005; Ip et al. 2000). We note
that we observed similar effects of SM on the mouse
intestine as previously reported by Kipp et al. (2009),
including increases in the expression of pathways linked to
translation, ribosomal proteins, and RNA processing. One
explanation for the differential effects at the gene expres-
sion level between selenomethionine and YS in our study is
that most selenomethionine found in YS is bound to pro-
teins, whereas selenomethionine in our study was provided
as the free amino acid. Differences in metabolism of free
and protein-bound selenomethionine may thus account for
some of the differences that we observed. A second
explanation is that other as yet uncharacterized selenium
compounds present in YS account for the differential
effects. Yeast-derived selenium contains several organic
selenium compounds in addition to SM, as well as the
putative cancer chemopreventive compound Se-methyl-Se-
cysteine (CH3SeCys) (McSheehy et al. 2005;I pe ta l .2000,
2002). Yet, another possibility is that free selenomethio-
nine is more readily oxidized than methionine, forming a
selenoxide as the reaction product (Zainal et al. 1998).
Therefore, dietary SM as a free amino acid may not
absorbed in this form but instead converted to a biologi-
cally less active derivative. Dietary SM can be incorpo-
rated nonspeciﬁcally into proteins or trans-selenated into
SeCys and subsequently H2Se, a compound that plays a
central role in selenium metabolism and serves as a pre-
cursor of selenophosphate. Selenophosphate serves as a
precursor to selenoprotein synthesis, as well as a precursor
to methylselenol, a putative cancer chemopreventive form
of selenium (Ip et al. 2002). In contrast, inorganic forms
such as SS undergo reductive metabolism, also yielding
H2Se. Because our data suggest striking similarities
between SS and YS at the gene expression level, it is
possible that similar to SS, the SM found in YS is prefer-
entially metabolized to H2Se as compared to free SM. Poor
selenium absorption from SM is unlikely to account for our
observations, given that SM resulted in high tissue levels of
selenium in our study, and recent ﬁndings in humans
showing higher selenium absorption when provided as SM
when compared to YS and SS (Reid et al. 2006).
There is an interest in the relationship among selenium
status, DNA damage, and cancer chemoprevention (Ray-
man 2005). A study that examined individuals in a high-
risk group for prostate cancer development identiﬁed a
signiﬁcant inverse correlation between DNA damage in
leukocytes and serum selenium levels (Waters et al. 2005).
Carriers of a BRCA1 mutation are at high risk for breast
cancer development, and this mutation is associated with
Table 2 Comparison between microarray and RT-PCR analyses for selected genes
Gene Tissue Microarray fold change (P value) RT-PCR fold change (P value)
SM SS YS SM SS YS
Gadd45b Gastrocnemius 1.02 (0.934) -2.42 (0.011) -2.16 (0.011) -1.16 (0.407) -1.48 (0.183) -1.87 (0.039)
Crkl Gastrocnemius -1.02 (0.801) -1.29 (0.002) -1.27 (0.001) -1.25 (0.000) -1.30 (0.000) -1.81 (0.000)
Tsc22d1 Liver 1.2 (0.591) 1.63 (0.136) 2.24 (0.002) -1.48 (0.136) 1.29 (0.271) 2.43 (0.030)
Sucnr1 Liver 1.12 (0.713) 1.25 (0.361) 1.75 (0.008) 1.03 (0.919) 1.03 (0.151) 2.17 (0.029)
Mapre2 Liver -1.30 (0.258) -3.10 (0.002) -3.71 (0.001) -1.33 (0.001) -1.33 (0.001) -1.84 (0.001)
Cyp7b1 Liver 1.12 (0.758) 1.62 (0.181) 1.47 (0.002) 1.24 (0.701) 1.61 (0.201) 1.60 (0.009)
Nfe2l2 Liver 1.00 (0.986) 1.48 (0.007) 1.59 (0.002) -1.28 (0.081) 1.30 (0.357) 1.43 (0.027)
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123increased DNA breakage in response to the oxidant bleo-
mycin (Kowalska et al. 2005). Supplementation with SS
normalizes chromosome breakage in this group, supporting
a role for selenium in preventing DNA damage or
enhancing its repair (Kowalska et al. 2005). However,
studies performed in dogs have shown a complex U-shaped
relationship between DNA damage in the prostate and
selenium levels in response to supplementation (Waters
et al. 2003, 2005). We have previously reported, using a
similar experimental design, that a selenium-deﬁcient diet
is associated with the induction of genes linked to DNA
damage and oxidative stress in the intestine, including
Gadd45b (Rao et al. 2001). Based on these observations,
we suggested that the gene expression proﬁle of low
selenium status may be associated with tumorigenesis (Rao
et al. 2001). We examined the expression of the DNA
damage response gene Gadd45b and found that YS con-
sistently lowered its expression in all tissues tested. SS
lowered Gadd45b expression in cortex and gastrocnemius,
and SM only reduced its expression in cortex. We also
observed that in liver, YS signiﬁcantly reduced the abun-
dance of the protein encoded by the Gadd45b gene. Finally,
we measured the levels of a marker of oxidative DNA
Fig. 4 Effect of selenium supplementation on selenoprotein gene
expression and enzyme activity. Values are means ± SEM; values
with different letters indicate statistically signiﬁcant differences
(P\0.05)
Fig. 5 Effect of selenium supplementation on markers of DNA
damage. Values are means ± SEM; values with different letters
indicate statistically signiﬁcant differences (P\0.05)
Fig. 3 Analysis of Gene Ontology (GO) terms changed by selenium
supplementation in four tissues of mice. Terms shown are those
signiﬁcantly changed by at least 2/3 treatments in each tissue
(P\0.001). Red indicates a GO term that was upregulated by
treatment (z-score[0); blue indicates GO terms that were downreg-
ulated by treatment (z-score\0)
b
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123damage (8-oxo-dG) in the liver and found a 27% reduction
in 8-oxo-dG in the YS diet, though this was not statistically
signiﬁcant. These ﬁndings are consistent with the recent
observation that the same source of YS used in our study
signiﬁcantly reduced both RNA and DNA oxidative dam-
age in the brain in the APP1/PS1 mouse model of
Alzheimer’s disease (Lovell et al. 2009). Thus, if increased
Gadd45b observed with SD reﬂects chronic cellular stress,
in our studies, YS appears to be the most effective form of
selenium opposing this stress.
Overall, our study suggests that the different forms of
selenium had a similar effect on the expression of selenium-
dependent genes and selenoenzyme activity; however, the
sources of selenium had differential effects on the overall
gene expression patterns (as noted by the similarity between
SSandYS)aswellasonspeciﬁcfunctionalpathwaysrelated
to mitochondrial structure and function. Importantly, we
observed that YS alone was associated with an enhanced
protection against DNA damage. We note that the SELECT
cancer chemoprevention trial was designed partly in
responseto the previous ﬁndings of the Nutrition Prevention
of Cancer (NPC) trial, which showed a 63% reduction in
prostatecancerinindividualsreceiving200 lg/dayofyeast-
derived selenium (Lippman et al. 2005). The divergent gene
expression proﬁles of SM, SS, and YS revealed in this study
clearly support the notion of non-equivalency for various
chemical forms of selenium and raise the possibility that the
choice of selenium source had an impact on the conﬂicting
results of the NPC and SELECT trials. We suggest that the
published data regarding the effect of selenium should be
re-evaluated with respect to the source of selenium that was
administered.
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